HP-hCG 5000IU by ZPHC is a peptide hormone commonly referenced in endocrine and reproductive system research contexts. It is used in models involving hormonal regulation, particularly where stimulation of endogenous testosterone production and testicular function is required during or after hormone suppression scenarios.

Active Ingredient and Dosage:
Each vial contains 5000 IU of human chorionic gonadotropin (hCG). The product is supplied as a single vial per pack, intended for controlled use in structured research protocols.

Usage and Benefits:
hCG is studied for its role in mimicking luteinizing hormone (LH), stimulating Leydig cells in the testes to produce testosterone. It is commonly referenced in research models involving recovery of endogenous hormone production following suppression, maintenance of testicular function, and fertility-related endocrine studies.

Mechanism of Action:
Human chorionic gonadotropin acts as an LH analog, binding to LH receptors in the testes to stimulate testosterone synthesis. This supports intratesticular testosterone production and helps maintain testicular function in conditions where natural LH secretion is reduced due to endocrine suppression.

Product Features:
– Potency: 5000 IU per vial
– Presentation: 1 vial per pack for targeted protocol use
– Injectable formulation for subcutaneous or intramuscular administration after reconstitution
– High-purity compound for consistent endocrine response in research settings
– Stable formulation designed to maintain potency during storage

Key Benefits:
– Supports restoration of endogenous testosterone production
– Helps prevent testicular atrophy in hormone suppression models
– Assists in post-cycle endocrine recovery protocols
– May support fertility-related parameters in male reproductive research models
– Allows flexible dosing strategies depending on protocol design

Recommended Use:
In research literature, hCG is commonly referenced in dosing ranges of approximately 500–1000 IU every other day, depending on protocol requirements and hormonal response. Administration is typically subcutaneous or intramuscular after proper reconstitution under controlled conditions.

Possible Side Effects:
– Headache or mild injection-site irritation
– Mood changes or irritability in some subjects
– Rare allergic reactions such as rash, itching, or swelling
– Potential overstimulation of testicular tissue with excessive dosing
– Hormonal fluctuations during endocrine adjustment phases

Contraindications:
Not recommended in individuals with hormone-sensitive cancers, prostate malignancies, or known hypersensitivity to hCG. Avoid use in pregnancy unless medically indicated under supervision.

Storage Conditions:
Store in a cool, dry place away from direct sunlight. Refrigerate after reconstitution and follow stability guidelines provided for injectable compounds.